pS2 and response to adjuvant hormone therapy in primary breast cancer

Br J Cancer. 1994 Feb;69(2):394-7. doi: 10.1038/bjc.1994.73.

Abstract

We reviewed 319 primary breast tumours for cytosolic pS2 content, with a median follow-up of 6 years. pS2 status correlated positively with oestradiol and progesterone receptors and negatively with Scarff, Bloom and Richardson grade. pS2 positivity was associated with longer overall survival, particularly in patients who received hormone therapy, in whom pS2 status was also predictive of the response to therapy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Breast Neoplasms / chemistry*
  • Breast Neoplasms / mortality
  • Breast Neoplasms / therapy*
  • Cytosol / chemistry*
  • Female
  • Follow-Up Studies
  • Humans
  • Middle Aged
  • Multivariate Analysis
  • Neoplasm Proteins / analysis*
  • Prognosis
  • Receptors, Estrogen / analysis
  • Receptors, Progesterone / analysis
  • Survival Analysis

Substances

  • Neoplasm Proteins
  • Receptors, Estrogen
  • Receptors, Progesterone